Serialization planning, data visibility and partner connectivity can help biopharma companies prepare complex therapies for ...

Formulation of high dose large molecules like proteins and biologics for injectables has created a great opportunity for ...

Highly potent active pharmaceutical ingredients are no longer a niche manufacturing challenge reserved for a limited set of ...

Fifty years was a milestone worth celebrating properly. So, we created a video that tells our story. It’s not just a look ...

Soobin Han of Marken, UPS Healthcare Precision Logistics discusses an evolution in APAC, from clinical trials to cold chain ...

This week on "The Friday Brief," license agreements were the theme, but there was also more M&A activity as we enter the ...

IQVIA is a global provider of clinical research services, healthcare data, advanced analytics, and technology solutions that ...

This week on "The Friday Brief," M&A activity tops the headlines, but plenty more deals dotted the pharma landscape.

The January 31, 2025, deadline for active clinical trials to transition to the European Union Clinical Trial Regulation as per the EU Clinical Trial Directive 2001/20/EC, which was in place for more ...

Ashland, a global provider of specialty pharmaceutical excipients, broke ground for a fourth Life Sciences’ aquarius film coatings manufacturing facility, located in Ambernath, Maharashtra, India. The ...

Testing for the presence of nitrosamines on pharmaceutical drug products will be a requirement on all prescription drugs, over-the-counter (OTC) drugs, and drug products in clinical development ...